🌱 created from: Relapsed Refractory Disease of Diffuse large B-cell lymphoma
2024-06-22-innovative_therapies_for_relapsed-refractory-disease-of-diffuse-large-b-cell-lymphoma
NOTE
🚩Bi- and tri-specific antibodies in non-hodgkin lymphoma: current data and perspectives Blood Cancer J. 2024;14(1):1-11 TL;DR: Abou Dalle. (2024) local: 📚 URL: 🌐 DOI: 📘 citekey🔑: [@aboudalle_bi_2024]